CRISPR gene editing to help immune cells target and kill cancer
New Scientist - 06-Feb-2020First CRISPR cancer trial in the world publish its promising findings
Edward Stadtmauer
Section Chief, Hematologic Malignancies, Perelman School of Medicine, University of Pennsylvania
Roseman, Tarte, Harrow, and Shaffer Families' President's Distinguished Professor
Department: Medicine
Contact Information
Division of Hematology Oncology
Perelman Center for Advanced Medicine
12th Floor, South Pavilion
Office #12-171
3400 Civic Center Blvd
Philadelphia, PA 19104
Perelman Center for Advanced Medicine
12th Floor, South Pavilion
Office #12-171
3400 Civic Center Blvd
Philadelphia, PA 19104
Office: 215-662-7910
Fax: 215-615-5888
Fax: 215-615-5888
Email: stadtmae@uphs.upenn.edu
Education:
A.B. (Biochemistry) Cornell University, College Of Arts And Sciences, 1979. M.D. (Medicine) University Of Pennsylvania School Of Medicine, 1983.
A.B. (Biochemistry) Cornell University, College Of Arts And Sciences, 1979. M.D. (Medicine) University Of Pennsylvania School Of Medicine, 1983.
Description of Research Expertise
Clinical trials, Bone Marrow TransplantDescription of Clinical Expertise
Myeloma, Leukemia, Lymphoma and Bone Marrow and Stem Cell TransplantVisit website: Edward Stadtmauer
See also: 
University of Pennsylvania
- Private Ivy League research university in Philadelphia, Pennsylvania
Details last updated 17-Feb-2020
Edward Stadtmauer News
